When combined with GNC's support program, we can expect the successful outcomes of GLP-1 therapy to grow as quickly as the program will," said John Olsen, president of Revive Pharmacy Solutions (a GNC Health partner), in a press release
The FDA resolved the semaglutide shortage in late 2024 and the tirzepatide shortage in early 2025, narrowing but not closing the legitimate window
: Credits SUN PHARMA #pharmivonmedia #IndustryNews #SunPharma #DCGI #WeightLossTherapy #PharmaInnovation #IndianPharma #HealthcareNews #pharmacy #healthcare #pharmd #medical #industry To view or add a comment, sign in Indias pharma market continues to expand, reaching 2.4 lakh crore in 2025 and projecting ~8% growth in 2026
The liraglutide group also showed a lower incidence of prediabetes and diabetes than the control group [11,13]
You draw 40 units thinking you are getting 2 mg
Skin and hair changes become visible